Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a retrospective, pharmacodynamic cohort analysis
Authors:
- 1 April 2017
- journal article
- clinical trial
- Published by Elsevier in The Lancet Haematology
- Vol. 4 (4) , e183-e191
Abstract
No abstract availableKeywords
Funding Information
- Rational Pharmacotherapy Programme (grant (40-41500-98-11044))
- Queen Wilhelmina Fund for cancer research (KWF; UU 2015-7601 and UU 2015-7553)
This publication has 36 references indexed in Scilit:
- Anti-thymocyte globulins for post-transplant graft-versus-host disease prophylaxis—A systematic review and meta-analysisCritical Reviews in Oncology/Hematology, 2013
- Immune Reconstitution Kinetics as an Early Predictor for Mortality using Various Hematopoietic Stem Cell Sources in ChildrenTransplantation and Cellular Therapy, 2013
- Impact of viral reactivations in the era of pre-emptive antiviral drug therapy following allogeneic haematopoietic SCT in paediatric recipientsBone Marrow Transplantation, 2012
- Thymic T-cell development in allogeneic stem cell transplantationBlood, 2011
- Pre-emptive treatment of acute GVHD: a randomized multicenter trial of rabbit anti-thymocyte globulin, given on day+7 after alternative donor transplantsBone Marrow Transplantation, 2009
- Total and Active Rabbit Antithymocyte Globulin (rATG;Thymoglobulin®) Pharmacokinetics in Pediatric Patients Undergoing Unrelated Donor Bone Marrow TransplantationTransplantation and Cellular Therapy, 2009
- Heterogeneous Clearance of Antithymocyte Globulin after CD34+-Selected Allogeneic Hematopoietic Progenitor Cell TransplantationTransplantation and Cellular Therapy, 2005
- Immune reconstitution after haematopoietic transplantation with two different doses of pre-graft antithymocyte globulinBone Marrow Transplantation, 2002
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantationThe Lancet, 1998